Recent Security Class Actions

aTyr Pharma Inc. Common Stock (NASDAQ: ATYR)

20 Days left to seek lead plaintiff status.

Company Name:aTyr Pharma Inc. Common Stock
Stock Symbol:NASDAQ: ATYR
Class Period Start:11/07/2024
Class Period End (inclusive):09/12/2025
Filing Deadline:12/08/2025

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the efficacy of Efzofitimod, particularly, the drug's capability to allow a patient to completely taper their steroid usage.

aTyr Pharma Inc. Common Stock (NASDAQ: ATYR) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address